Introduction {#s1}
============

The human dental follicle or dental sac is a loose ectomesenchymally derived connective tissue that surrounds the enamel organ and dental papilla of the developing tooth germ prior to eruption\[[@B1]\]. One of the biological functions of the dental follicle is the coordination of tooth eruption. Moreover, this tissue harbors progenitor cells for the periodontium\[[@B2]\], which, as the supporting tissue of the tooth, is composed of the periodontal ligament (PDL), alveolar bone, and the cementum that covers the tooth root surfaces\[[@B3]\]. The PDL tissue functions as a connector between the tooth and the alveolar jaw bone in the area surrounding the root surfaces\[[@B4]\]. Since the PDL originates from the dental follicle in tooth development, comparative gene-expression analyses may identify the unique features and specific functions of the two other dental tissues (i.e., alveolar bone and cementum).

The introduction of cDNA microarray technology, which has become one of the standard laboratory tools for gene-expression analysis, has made it possible to analyze thousands of genes simultaneously. This technique has been used in the following three ways in dental research:

1.  1\. To verify genes related to diseases or abnormal states, such as ameloblastoma\[[@B5]\], dental caries\[[@B6],[@B7]\], and the PDL under mechanical stress *in* *vitro*\[[@B8]\].

2.  2\. To compare two similar normal tissues in order to determine subtle genetic differences, such as permanent PDL/deciduous PDL\[[@B8]\], fibroblast in the PDL/gingiva *in* *vitro*\[[@B9]\].

3.  3\. To compare two different tissues that share the same origin, such as odontoblast/pulp tissue\[[@B10]\].

Such research has revealed the gene expression of the human tooth. However, no comparative study has yet been made of the dental follicle and PDL.

The present study evaluated and compared the gene-expression profiles of the dental follicle and PDL in humans with the aim of explaining their functions, such as eruption coordination and stress resorption. This information may be applicable to clinical problems such as eruption disturbance, and to periodontal tissue engineering.

Materials and Methods {#s2}
=====================

1. Samples {#s2.1}
----------

The experimental protocol was approved by the Institutional Review Board of Yonsei University Dental Hospital, and written informed consent to participate in the study was obtained from all of the subjects and their parents (\#2-2011-0055). PDL samples were obtained from healthy permanent premolars (*n*=11; 1 male and 4 females, aged 11--19 years) that had been extracted for orthodontic reasons. Dental follicles were obtained from children (*n*=4; 3 males and 1 female, aged 6--7 years) during the extraction of supernumerary teeth. The extracted teeth and dental follicles were immediately frozen and stored in liquid nitrogen. The PDL tissues were obtained carefully using sterile curettes from the middle-third. The PDL tissues and dental follicles were then immediately submerged in RLT buffer, the component of the RNeasy Fibrous Mini kit (Qiagen, CA, USA).

2. RNA isolation {#s2.2}
----------------

The dental follicle and PDL tissues were homogenized separately using a Bullet Blender Bead (Next Advanced, NY, USA), and total RNA was extracted from the homogenates using the RNeasy Fibrous Mini kit (Qiagen) in accordance with the manufacturer's instructions and as described previously\[[@B8]\]. The extracted RNA was eluted in 25 μl of sterile water and RNA concentrations were determined from absorbance values obtained at a wavelength of 260 nm as measured with the aid of a spectrophotometer (NanoDrop ND-1000, Thermo Scientific, IL, USA). The RNA samples used in this study had 260/280 nm ratios equal to or greater than 1.8.

3. cDNA microarray analysis {#s2.3}
---------------------------

In the present study, global gene-expression analyses were performed using Affymetrix GeneChip Human Gene 1.0 ST oligonucleotide arrays (Affymetrix, CA, USA). The sample preparation was conducted in accordance with the manufacturer's instructions and recommendations. The average amount of RNA isolated from dental follicles or PDL tissues was 1 μg. RNA quality was assessed with the aid of an Agilent 2100 bioanalyzer using the RNA 6000 Nano Chip system (Agilent Technologies, Amstelveen, The Netherlands), and the quantity was determined using the NanoDrop ND-1000 device (Thermo Scientific).

As recommended by the manufacturer's protocol, 300 ng of total RNA from each sample was converted to double-strand cDNA. Using a random hexamer incorporating a T7 promoter, amplified RNA (cRNA) was generated from the double-stranded cDNA template though an *in vitro* transcription reaction and purified with the Affymetrix sample cleanup module. cDNA was regenerated through a random-primed reverse transcription (RT) using a dNTP mix containing dUTP. The cDNA was then fragmented by uracil-DNA glycosylase and apurinic/apyrimidinic endonuclease and restriction endonucleases, and end-labeled by terminal transferase reaction incorporating a biotinylated dideoxynucleotide. Fragmented end-labeled cDNA was hybridized to the GeneChip Human Gene 1.0 ST arrays for 16 hours at 45°C and 60 rpm, as described in the GeneChip Whole Transcript Sense Target Labeling Assay manual (Affymetrix). After hybridization, the chips were stained and washed in a GeneChip Fluidics Station 450 (Affymetrix) and scanned using a GeneChip Array scanner 3000 G7 (Affymetrix); the image data were extracted using Affymetrix Command Console software version 1.1 (Affymetrix). The raw file generated through this procedure contained expression intensity data and was used for the next step of the analysis.

4. Microarray data analysis {#s2.4}
---------------------------

The expression data were generated by Affymetrix Expression Console software version 1.1 (Affymetrix). The Robust Multi-array Average (RMA) algorithm implemented in the Affymetrix Expression Console software was used to normalize the data. A one-way ANOVA was performed on the RMA expression values to determine whether genes were differentially expressed between the three groups. A multiple-testing correction was applied to the *p* values of the *F*-statistics to adjust the false discovery rate (Benjamini and Hochberg, 1995). Genes with adjusted *F*-statistic *p* values of \<0.05 were extracted. Microarray analysis identified 490 genes with expression differences of twofold or greater, 365 and 125 of which were more abundant in the dental follicle and PDL tissue, respectively. However, only strongly expressed genes in the dental follicles or PDL that differed by more than 4- or 2.5-fold from the signal of the control and each test group, respectively, were selected for further study. In order to classify the coexpression gene group with a similar expression pattern, hierarchical clustering and K-mean clustering were performed using MultiExperiment Viewer software version 4.4 (www.tm4.org; Dana-Farber Cancer Institute, MA, USA). The Web-based tool Database for Annotation, Visualization, and Integrated Discovery (DAVID) was used for the biological interpretation of differentially expressed genes. These genes were classified based on data on gene function in the gene ontology of the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway database ([[http://david.abcc.ncifcrf.gov/home.jsp]{.ul}](http://david.abcc.ncifcrf.gov/home.jsp)).

This microarray data set was approved by the Gene Expression Omnibus ([[http://www.ncbi.nlm.gov/geo/]{.ul}](http://www.ncbi.nlm.gov/geo/)); its GEO accession number is GSE51342.

5. Quantitative reverse-transcription polymerase chain reaction {#s2.5}
---------------------------------------------------------------

The single-stranded cDNA required for the polymerase chain reaction (PCR) analysis was produced using 500 ng of extracted total RNA as a template for RT (Superscript III Reverse Transcriptase and random primer, Invitrogen, UK). The RT reaction was performed at 65°C for 5 minutes, followed by 25°C for 5 minutes, 50°C for 1 hour, and 70°C for 15 minutes to inactivate the activity of the reverse transcriptase. The synthesized cDNA was diluted at 10:1 in distilled water and used as a template for quantitative RT-PCR, which was performed using the ABI7300 RT-PCR system (Applied Biosystems, Warrington, UK). Samples of 25 μl containing 1× Universal TaqMan Master Mix (4369016, Applied Biosystems), PCR primers at a concentration of 0.9 μM, and the diluted cDNA were prepared in triplicate. The amplification conditions were 50°C for 2 minutes and 95°C for 10 minutes followed by 40 cycles of 95°C for 15 seconds and 60°C for 1 minute. The following TaqMan gene-expression assay primers (Applied Biosystems) were used: *AMTN*, *CD36*, *CXCL13*, *DMP1*, *EGFL6*, *MMP8*, *MMP9*, *WIF1*, and 18S rRNA. ABI 7300 SDS 1.3.1 software (Applied Biosystems) was used to record the fluorescence intensity of the reporter and quencher dyes; the results are plotted versus time, quantified as the cycle number. A precise quantification of the initial target was obtained by examining the amplification plots during the early log phase of product accumulation above background \[the threshold cycle (Ct) number\]. Ct values were subsequently used to determine ΔCt values (ΔCt=Ct of the gene minus Ct of the 18S rRNA control), and differences in Ct values were used to quantify the relative amount of PCR product, expressed as the relative change by applying the equation 2^--ΔCt^.

6. Immunohistochemical staining {#s2.6}
-------------------------------

For immunohistochemical (IHC) staining, permanent teeth were fixed in 10% buffered formalin (Sigma, MO, USA) for 1 day and then decalcified with 10% EDTA (pH 7.4; Fisher Scientific, TX, USA) for 8 weeks. The dental follicles and the permanent teeth were embedded in paraffin, and sectioned at a thickness of 3 μm. Specimens were subjected to IHC staining with antihuman AMTN (rabbit polyclonal, diluted 1:100; Ab122312, Abcam, Cambridge, UK), CXCL13 (BCA1, rabbit polyclonal, diluted 1:200; Ab112521, Abcam), DMP1 (rabbit polyclonal, diluted 1:100; Ab82351, Abcam), WIF1 (rabbit polyclonal, diluted 1:100; Ab71204, Abcam), and MMP9 (rabbit polyclonal, diluted 1:800; Ab38898, Abcam). The endogenous peroxidase activity was quenched by the addition of 3% hydrogen peroxide. Sections were incubated in 5% bovine serum albumin to block nonspecific binding. The primary antibodies in which the sections were incubated overnight were diluted so as to optimize the staining. After incubation, ready to use EnVision+ System HRP-labeled polymer antirabbit (K4003, ready to use; Dako North America, CA, USA) was applied for 20 minutes. Color development was performed using labeled streptavidin biotin kits (Dako) following the manufacturer's instructions. The sections were counterstained with Gill's hematoxylin (Sigma). Control sections were treated in the same manner except for the treatment with primary antibodies.

Results {#s3}
=======

1. Dental follicle and PDL gene-expression profiles {#s3.1}
---------------------------------------------------

Complementary DNA microarray technology was used to compare multiple gene-expression profiles representative of the dental follicle and PDL tissues. The results indicated that the expression levels of 490 out of 33,297 (1.49%) genes had changed by at least twofold in one tissue type relative to the other. In the dental follicle, the expression levels of 365 genes were at least double those in the PDL, while in the latter, the expression levels of 125 genes were at least double those in dental follicle tissue. The total data distribution and frequency were confirmed in density and box plots and in scatter plots of the standardized log intensity ratio versus the average intensity ([Figure S1](#pone.0084201.s001){ref-type="supplementary-material"}). Ultimately, 108 genes were analyzed further. In dental follicle tissue, 55 genes were up-regulated by at least fourfold relative to PDL tissue ([Table 1](#pone-0084201-t001){ref-type="table"}), while 53 genes were up-regulated by at least 2.5-fold in the PDL relative to dental follicle tissue ([Table 2](#pone-0084201-t002){ref-type="table"}).

10.1371/journal.pone.0084201.t001

###### Up-regulated genes in the dental follicle tissue (compared to periodontal ligament tissue).

  **Name**                                                                                 **Gene symbol**   **Fold change**   **Gene Accession**   **Cytoband**
  ---------------------------------------------------------------------------------------- ----------------- ----------------- -------------------- ----------------
  ameloblastin (enamel matrix protein)                                                     AMBN              94.88             NM_016519            4q21
  amelotin                                                                                 AMTN              22.23             NM_212557            4q13.3
  EGF-like-domain, multiple 6                                                              EGFL6             17.76             NM_015507            Xp22
  microfibrillar associated protein 5                                                      MFAP5             14.29             NM_003480            12p13.1-p12.3
  leucine-rich repeat-containing G protein-coupled receptor 5                              LGR5              12.93             NM_003667            12q22-q23
  neuronal growth regulator 1                                                              NEGR1             12.85             NM_173808            1p31.1
  coagulation factor II (thrombin) receptor-like 2                                         F2RL2             10.99             NM_004101            5q13
  hydroxyprostaglandin dehydrogenase 15-(NAD)                                              HPGD              10.66             NM_000860            4q34-q35
  gamma-aminobutyric acid (GABA) A receptor, alpha 3                                       GABRA3            9.60              NM_000808            Xq28
  PDZ domain containing ring finger 4                                                      PDZRN4            8.61              NM_013377            12q12
  frizzled-related protein                                                                 FRZB              8.26              NM_001463            2qter
  statherin                                                                                STATH             7.57              NM_003154            4q13.3
  triadin                                                                                  TRDN              7.31              NM_006073            6q22.31
  chemokine (C-X-C motif) ligand 13                                                        CXCL13            7.21              NM_006419            4q21
  leucine rich repeat neuronal 1                                                           LRRN1             7.10              NM_020873            3p26.2
  C1q and tumor necrosis factor related protein 3                                          C1QTNF3           7.09              NM_181435            5p13
  spondin 1, extracellular matrix protein                                                  SPON1             6.66              NM_006108            11p15.2
  ectonucleotidepyrophosphatase/phosphodiesterase 5 (putative)                             ENPP5             6.52              NM_021572            6p21.1-p11.2
  epithelial cell adhesion molecule                                                        EPCAM             6.41              NM_002354            2p21
  solute carrier family 4, sodium bicarbonate cotransporter, member 4                      SLC4A4            6.33              NM_001098484         4q21
  ALX homeobox 1                                                                           ALX1              6.29              NM_006982            12q21.31
  NADPH oxidase 4                                                                          NOX4              6.23              NM_016931            11q14.2-q21
  fibroblast growth factor 7                                                               FGF7              5.75              NM_002009            15q21.2
  matrix metallopeptidase 8 (neutrophil collagenase)                                       MMP8              5.58              NM_002424            11q22.3
  small nucleolar RNA, C/D box 114-26                                                      SNORD114-26       5.58              NR_003219            14q32
  sarcoglycan, zeta                                                                        SGCZ              5.49              NM_139167            8p22
                                                                                           \-\--             5.38              \-\--                \-\--
  hyaluronan and proteoglycan link protein 1                                               HAPLN1            5.12              NM_001884            5q14.3
  CD24 molecule                                                                            CD24              4.94              NM_013230            6q21
  transient receptor potential cation channel, subfamily A, member 1                       TRPA1             4.86              NM_007332            8q13
  carboxypeptidase X (M14 family), member 2                                                CPXM2             4.85              NM_198148            10q26.13
  paternally expressed 10                                                                  PEG10             4.75              NM_015068            7q21
  sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A   SEMA3A            4.67              NM_006080            7p12.1
  flavin containing monooxygenase 3                                                        FMO3              4.66              NM_006894            1q24.3
  wingless-type MMTV integration site family member 2                                      WNT2              4.65              NM_003391            7q31.2
  thrombospondin 4                                                                         THBS4             4.62              NM_003248            5q13
  pappalysin 2                                                                             PAPPA2            4.59              NM_020318            1q23-q25
  G protein-coupled receptor 64                                                            GPR64             4.53              NM_001079858         Xp22.13
  elongation of very long chain fatty acids (FEN1/Elo2, SUR4/Elo3, yeast)-like 2           ELOVL2            4.51              NM_017770            6p24.2
  calcium channel, voltage-dependent, alpha 2/delta subunit 3                              CACNA2D3          4.48              NM_018398            3p21.1
  complement component 3                                                                   C3                4.46              NM_000064            19p13.3-p13.2
  collagen, type XIV, alpha 1                                                              COL14A1           4.36              NM_021110            8q23
  Ras protein-specific guanine nucleotide-releasing factor 2                               RASGRF2           4.31              NM_006909            5q13
  activated leukocyte cell adhesion molecule                                               ALCAM             4.30              NM_001627            3q13.1
  neural cell adhesion molecule 2                                                          NCAM2             4.23              NM_004540            21q21.1
  dickkopf homolog 2 (Xenopuslaevis)                                                       DKK2              4.22              NM_014421            4q25
  hemicentin 1                                                                             HMCN1             4.20              NM_031935            1q25.3-q31.1
  core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1      C1GALT1           4.17              NM_020156            7p14-p13
  NEL-like 1 (chicken)                                                                     NELL1             4.16              NM_006157            11p15.1
  chromosome 12 open reading frame 75                                                      C12orf75          4.14              NM_001145199         12q23.3
  odz, odd Oz/ten-m homolog 2 (Drosophila)                                                 ODZ2              4.13              AK302302             5q34
  paired box 3                                                                             PAX3              4.09              NM_181458            2q35-q37\|2q35
  solute carrier family 38, member 1                                                       SLC38A1           4.08              NM_030674            12q13.11
  gremlin 1                                                                                GREM1             4.04              NM_013372            15q13.3
  solute carrier family 1 (glial high affinity glutamate transporter), member 3            SLC1A3            4.01              NM_004172            5p13
  Kallmann syndrome 1 sequence                                                             KAL1              4.00              NM_000216            Xp22.32
  microfibrillar-associated protein 4                                                      MFAP4             3.97              NM_001198695         17p11.2
  dermatan sulfate epimerase-like                                                          DSEL              3.96              NM_032160            18q22.1
  laminin, alpha 2                                                                         LAMA2             3.95              NM_000426            6q22-q23
  vesicle amine transport protein 1 homolog (T. californica)-like                          VAT1L             3.91              NM_020927            16q23.1
  chemokine (C-C motif) ligand 2                                                           CCL2              3.88              NM_002982            17q11.2-q12

10.1371/journal.pone.0084201.t002

###### Up-regulated genes in the periodontal ligament tissue (compared to dental follicle).

  **Name**                                                                                                    **Gene symbol**     **Fold change**     **Gene access**   **cytoband**
  ----------------------------------------------------------------------------------------------------------- ------------------- ------------------- ----------------- ---------------
  WNT inhibitory factor 1                                                                                     WIF1                12.63               NM_007191         12q14.3
  dentin matrix acidic phosphoprotein 1                                                                       DMP1                10.67               NM_004407         4q21
  acid phosphatase 5, tartrate resistant                                                                      ACP5                6.78                NM_001111035      19p13.3-p13.2
  small proline-rich protein 2A                                                                               SPRR2A              6.60                NM_005988         1q21-q22
  bone morphogenetic protein 8a                                                                               BMP8A               6.15                NM_181809         1p34.3
  transmembrane 4 L six family member 19                                                                      TM4SF19             6.12                NM_138461         3q29
  tenascin N                                                                                                  TNN                 6.02                NM_022093         1q23-q24
  stathmin-like 2                                                                                             STMN2               5.57                NM_007029         8q21.13
  bone gamma-carboxyglutamate (gla) protein                                                                   BGLAP               5.10                NM_199173         1q25-q31
  signal peptide, CUB domain, EGF-like 3                                                                      SCUBE3              4.55                NM_152753         6p21.3
  CD36 molecule (thrombospondin receptor)                                                                     CD36                4.54                NM_001001548      7q11.2
  ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2                                                     ATP6V0D2            4.25                NM_152565         \-\--
  small Cajal body-specific RNA 17                                                                            SCARNA17            4.21                NR_003003         18q21.1
  matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase)                       MMP9                4.20                NM_004994         20q11.2-q13.1
  multiple EGF-like-domains 10                                                                                MEGF10              4.14                NM_032446         5q33
  interleukin 1, beta                                                                                         IL1B                4.11                NM_000576         2q14
  G protein-coupled receptor 109B                                                                             GPR109B             4.10                NM_006018         12q24.31
  interleukin 8                                                                                               IL8                 4.07                NM_000584         4q13-q21
  \-\--                                                                                                       \-\--               3.98                \-\--             \-\--
  anoctamin 5                                                                                                 ANO5                3.94                NM_213599         11p14.3
  integrin-binding sialoprotein                                                                               IBSP                3.91                NM_004967         4q21.1
  matrix metallopeptidase 3 (stromelysin 1, progelatinase)                                                    MMP3                3.80                NM_002422         11q22.3
  matrix extracellular phosphoglycoprotein                                                                    MEPE                3.73                NM_001184694      4q21.1
  interferon, gamma-inducible protein 30                                                                      IFI30               3.61                NM_006332         19p13.1
  creatine kinase, brain                                                                                      CKB                 3.46                NM_001823         14q32
  integrin, alpha 10                                                                                          ITGA10              3.42                NM_003637         1q21
  small Cajal body-specific RNA 17                                                                            SCARNA17            3.38                NR_003003         18q21.1
  \-\--                                                                                                       \-\--               3.29                \-\--             \-\--
  BMP and activin membrane-bound inhibitor homolog (Xenopuslaevis)                                            BAMBI               3.19                NM_012342         10p12.3-p11.2
  pannexin 3                                                                                                  PANX3               3.18                NM_052959         11q24.2
  solute carrier family 37 (glycerol-3-phosphate transporter), member 2                                       SLC37A2             3.18                NM_198277         11q24.2
  transcription factor AP-2 beta (activating enhancer binding protein 2 beta)                                 TFAP2B              3.14                NM_003221         6p12
  bone morphogenetic protein 3                                                                                BMP3                3.09                NM_001201         4q21
  distal-less homeobox 1                                                                                      DLX1                2.98                NM_178120         2q32
  interferon induced transmembrane protein 5                                                                  IFITM5              2.97                NM_001025295      11p15.5
  bone morphogenetic protein 8b                                                                               BMP8B               2.94                NM_001720         1p35-p32
  myelin protein zero                                                                                         MPZ                 2.93                NM_000530         1q23.3
  MAM domain containing 2                                                                                     MAMDC2              2.91                NM_153267         9q21.12
  dachsous 2 (Drosophila)                                                                                     DCHS2               2.90                NM_017639         4q31.3
  chondroadherin                                                                                              CHAD                2.85                NM_001267         17q21.33
  serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1               SERPINE1            2.83                NM_000602         7q21.3-q22
  selectin E                                                                                                  SELE                2.77                NM_000450         1q22-q25
  transmembrane 7 superfamily member 4                                                                        TM7SF4              2.77                NM_030788         8q23
  aquaporin 9                                                                                                 AQP9                2.76                NM_020980         15q
  protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 2   PPFIA2              2.76                NM_003625         12q21.31
  phospholipase A2, group IIA (platelets, synovial fluid)                                                     PLA2G2A             2.75                NM_000300         1p35
  lysophosphatidic acid receptor 3                                                                            LPAR3               2.71                NM_012152         1p22.3
  rhomboid, veinlet-like 2 (Drosophila)                                                                       RHBDL2              2.69                NM_017821         1p34.3
  \-\--                                                                                                       \-\--               2.67                \-\--             \-\--
  discs, large (Drosophila) homolog-associated protein 5                                                      DLGAP5              2.64                NM_014750         14q22.3
  major histocompatibility complex, class II, DQ alpha 1                                                      HLA-DQA1            2.60                NM_002122         6p21.3
  von Willebrand factor D and EGF domains                                                                     VWDE                2.58                NM_001135924      7p21.3
  family with sequence similarity 40, member B                                                                FAM40B              2.57                NM_020704         7q32.1
  chemokine (C-X-C motif) receptor 1                                                                          CXCR1               2.57                NM_000634         2q35
  retinol binding protein 4, plasma                                                                           RBP4                2.52                NM_006744         10q23-q24
  G protein-coupled receptor 109A                                                                             GPR109A             2.50                NM_177551         12q24.31
  microRNA 487a                                                                                               MIR487A             2.50                NR_030162         14q32.31

2. Gene-ontology analysis {#s3.2}
-------------------------

In order to identify the biological functions and features of the selected genes, the expressed data sets were organized into Gene Ontology Consortium (GO) grouping using the DAVID Web-based tool. These genes were then classified based on information regarding gene function using gene ontology from the KEGG pathway database. [Figure 1](#pone-0084201-g001){ref-type="fig"} show GO classes with *F*-statistic *p* values of \<0.05 for the two data sets analyzed.

![Gene-ontology analysis of the periodontal ligament(PDL) and the dental follicle.\
a. Main categories of genes expressed specifically in the dental follicle and periodontal ligament (PDL) tissues on the basis of their biological processes. b. Main categories of genes expressed specifically in dental follicle and PDL tissues on the basis of their molecular function (*x*-axis: number of involved genes, *F*-statistic *p*\<0.05).](pone.0084201.g001){#pone-0084201-g001}

Biological process analysis revealed that genes related to cell surface receptor-linked signal transduction, cell adhesion, biological adhesion, neurologic system processes, and Wnt receptor signaling pathway were more strongly expressed in dental follicle tissue than in the PDL. Moreover, molecular function analysis revealed that genes related to ion binding, cation binding, metal ion binding, and calcium ion binding were more strongly expressed in dental follicle tissue than in the PDL.

3. Quantitative RT-PCR {#s3.3}
----------------------

Quantitative RT-PCR analysis was performed to verify the results obtained through cDNA microarray. The eight genes with expression levels differing by at least twofold between dental follicle tissue and the PDL were selected ([Table S1](#pone.0084201.s002){ref-type="supplementary-material"}). For the statistical analysis, the unpaired *t*-test (α\<0.05) was performed to correlate the relative change with differential expression as detected by PCR. *AMTN*, *EGFL-6*, *CXCL13*, and *MMP8* were up-regulated in dental follicle tissue relative to the PDL, while *DMP1*, *WIF1* and *CD36* were up-regulated in PDL tissue relative to the dental follicle ([Table 3](#pone-0084201-t003){ref-type="table"}). The expression of *MMP9* did not differ between dental follicle tissue and PDL tissue. These results are consistent with the microarray results.

10.1371/journal.pone.0084201.t003

###### The relative difference in gene mRNA expression in dental follicle and periodontal ligament tissue.

  Gene                                             Relative Gene Expression (mean±SD)   
  ------------------------------------------------ ------------------------------------ --------------
  *AMTN[\*\*](#nstab3.1){ref-type="table-fn"}*     2741.88±245.81                       1
  *EGFL-6[\*\*](#nstab3.1){ref-type="table-fn"}*   265.40±79.19                         1
  *CXCL13[\*\*](#nstab3.1){ref-type="table-fn"}*   12.15±1.23                           1
  *MMP8[\*\*](#nstab3.1){ref-type="table-fn"}*     3.48±0.70                            1
  *DMP1[\*\*](#nstab3.1){ref-type="table-fn"}*     1                                    51.59±14.64
  *WIF1[\*\*](#nstab3.1){ref-type="table-fn"}*     1                                    233.17±24.40
  *CD36[\*\*](#nstab3.1){ref-type="table-fn"}*     1                                    5.32±1.26
  *MMP9*                                           1                                    1.34±0.26

^\*\*^ *p*\<0.01

4. IHC staining {#s3.4}
---------------

The following five genes were the targets of the IHC study: *AMTN*, *CXCL13*, *DMP1*, *WIF1*, and *MMP9* ([Figure 2](#pone-0084201-g002){ref-type="fig"}). *AMTN* staining was found only in the reduced enamel epithelium of the dental follicle. *CXCL13* was broadly stained in the outer area of the dental follicles, and in Hertwig's epithelial root sheath (HERS). *DMP1* was not stained in dental follicle tissue, but was found around the cementoblast layer. Similarly, *WIF1* was not stained in dental follicle tissue but was strongly stained in permanent PDL tissues, especially in the cementoblast layer. *MMP9* was broadly stained in the outer area of the dental follicle but also in all layers of permanent PDL tissue. These results are consistent with those of the cDNA microarray analysis at the protein level.

![Immunohistochemical (IHC) staining of dental follicle and permanent PDL tissues.\
(**A**, **F**) IHC staining for AMTN in the dental follicle and (**K**, **P**) permanent PDL tissues. (**B**, **G**) IHC staining for CXCL13 in the dental follicle and (**L**, **Q**) permanent PDL tissue. (**C**, **H**) IHC staining for DMP1 in the dental follicle and (**M**, **R**) permanent PDL tissue. (**D**, **I**) IHC staining for WIF1 in the dental follicle and (**N**, **S**) permanent PDL tissue. (**E**, **J**) IHC staining for MMP9 in the dental follicle and (**O**, **T**) permanent PDL tissue. (Scale bars: 20 μm in **A--E** and **P--T**; 100 μm in F--O.)](pone.0084201.g002){#pone-0084201-g002}

Discussion {#s4}
==========

The cDNA microarray results indicate that the expression levels of 490 out of 33,297 (1.49%) genes had changed by at least twofold in one tissue type relative to the other. Although this finding is not dissimilar to that of McLachlan et al.\[[@B7]\] in dental caries (445/15,000, 2.96%), Song \[[@B8]\] reported that only 51 of \>20,000 genes (≤0.25%) were differentially expressed between the PDLs of permanent teeth and deciduous teeth. Differences in the homogeneity between dental follicle and PDL tissue from different tooth types may explain this discrepancy, with PDL tissues from different tooth types possibly being more homogeneous than the dental follicle.

In general, genes associated with bone development and remodeling (*EGFL6*, *MMP8*, *FRZB*, and *NELL1*), apoptosis and chemotaxis (*Nox4*, *CXCL13*, and *CCL2*), and tooth and embryo development (*WNT2*, *PAX3*, *FGF7*, *AMBN*, *AMTN*, and *SLC4A4*) were more strongly expressed in the dental follicle than in the PDL. These genes are thought to be associated with the biological function of dental follicle tissue, such as eruption coordination.

In detail, bone remodeling requires an intimate cross-talk between osteoclasts and osteoblasts. *EGFL6*, a member of the epidermal growth factor repeat superfamily of proteins, induces angiogenesis via a paracrine mechanism in which *EGFL6* is expressed in osteoblast-like cells but promotes the migration and angiogenesis of endothelial cells \[[@B11]\]. *MMP8* is involved in the breakdown of extracellular matrix in normal physiological processes, such as tissue remodeling\[[@B12]\]. *FRZB* (frizzled motif associated with bone development) plays an important role in bone development \[[@B13]\]. *NELL1* promotes osteoblast cell differentiation and mineralization. *Runx2*, *Osterix*, and *NELL1* promote crosstalk during osteogenesis \[[@B14]\].

*Nox4* promotes the apoptosis of oral epithelium at the eruption site and so is thought to be related to the tooth-eruption mechanism \[[@B15]\]. *CXCL13* \[chemokine (C-X-C motif) ligand 13\] promotes the migration of B lymphocytes and is strongly expressed in the liver, spleen, and lymph nodes \[[@B16]\]. The number of *CXCL13* cells is reportedly significantly higher in periodontitis, suggesting that this condition is associated with alveolar bone resorption. *CCL2* (*MCP-1*) is a well-known chemokine for monocytes and a prime candidate for recruiting the osteoclast precursors into dental follicle tissue \[[@B17]\].

Genes associated with tooth and embryo development were also significantly more strongly expressed in the dental follicle than in the PDL. *WNT2* is a member of the WNT gene family, and the Wnt pathway is crucial for tooth development, embryogenesis, and odontoblast and ameloblast differentiation \[[@B18]\]. Previous studies found that Wnt signaling inhibits cell differentiation and promotes cell proliferation in cementoblasts *in vitro* \[[@B19]\]. Furthermore, the Wnt signaling pathways may participate in the formation of the tooth eruption passage \[[@B15]\].

The tumor-suppressor gene *WIF1* was the most strongly expressed in the PDL. In addition, genes associated with wound healing (*IL1*, *IL8*, *MMP3*, and *MMP9*) and bone development and remodeling (*STMN2*, *IBSP*, *BMP8A*, *BGLAP*, *ACP5*, *OPN*, *BMP3*, *TM7SF4*) were up-regulated relative to the dental follicle.

*WIF1* was the most strongly expressed gene in the PDL, which means that, conversely, the Wnt signal would have been strongly expressed in dental follicle tissue. WNT2 and DKK2 are associated with WNT signaling, and the genes encoding both were strongly expressed in the dental follicle in this study. The Wnt signaling pathway has been implicated in a wide range of biological process, from maintaining the pluripotentiality of stem cells to the induction of specific tissues and organs during development. *WIF1* functions as a tumor-suppressor gene, and it has been shown to be epigenetically silenced in various cancers\[[@B20]\]. Genes related to wound healing were significantly strongly expressed. *IL1* and *IL8* are important mediators of the inflammatory response and play an important role in the induction of osteoclastic bone resorption during orthodontic tooth movement \[[@B21]\]. *MMP3* and *MMP9* are regulated by fibroblasts in the PDL and are induced in fibroblasts and immune cells that are recruited in the pathologic situation \[[@B22]\].

Genes associated with bone development and remodeling were significantly more strongly expressed in the PDL than in the dental follicle. *STMN2* is a novel marker of osteogenesis and osteoblasts \[[@B23]\]. IBSP (integrin-binding sialoprotein) is a major structural protein of the bone matrix \[[@B24]\]. *BMP8A* is related to osteogenesis and skeletal development \[[@B24],[@B25]\]. *BGLAP* (osteocalcin) was first identified in the mineralized matrix of bone and is associated with bone development \[[@B26]\]. *ACP5* (TRAP) exhibits optimal activity in acidic conditions and is strongly expressed by osteoclasts, activated macrophages, and neurons. *OPN* and bone sialoprotein are strongly associated with TRAP when phosphorylated \[[@B27]\]. *BMP3* is a major structural protein of the bone matrix and osteoclast activity in fractured sites. This gene is a member of the transforming growth factor beta superfamily and is localized to the latest stage of periodontium formation by inhibiting the signaling provided by other bone morphogenetic proteins \[[@B28]\]. *TM7SF4* is related to osteoclastogenesis and the regulation of osteoclast fusion \[[@B29]\].

Quantitative RT-PCR analyses were carried out to verify our cDNA microarray results. *AMTN*, *EGFL-6*, *CXCL13*, and *MMP8* were up-regulated in dental follicle tissue relative to the PDL, while *DMP1*, *WIF1* and *CD36* were up-regulated in the PDL tissue relative to the dental follicle. These findings are consistent with the microarray results.

To better understand the roles of the differentially expressed genes identified by the microarray analyses between dental follicle and PDL tissues in humans, their cellular origins were identified using IHC analysis. *AMTN* was found only in the reduced enamel epithelium of dental follicle tissue. *CXCL13* was broadly stained in the outer area of the dental follicle and in HERS. *DMP1* was not stained in the dental follicle, but was found around the cementoblast layer. *WIF1* was not stained in dental follicles, but was strongly stained in permanent PDL tissue, especially the cementoblast layer. *MMP9* was broadly stained in the outer area of the dental follicles, but also strongly in all layers of permanent PDL tissue ([Figure 2](#pone-0084201-g002){ref-type="fig"}). These results are consistent with those of the cDNA microarray analysis at the protein level.

In conclusion, genes associated with bone development and remodeling were strongly expressed in both PDL and dental follicle tissues, and *in vivo* would induce tooth eruption or tooth movement. The two tissues also expressed specific genes related to their functions. Interestingly, *WIF1*, which was strongly expressed in the PDL, is thought to represent a counter example of the pluripotentiality of the stem cells of the dental follicle. The findings of this study are expected to contribute to future research in the field of clinical problems such as eruption disturbance, and to research in periodontal tissue engineering by demonstrating the differences between the PDL and dental follicle tissues at the molecular biological level.
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**Scatter plots of the differences in the log intensities versus the average log intensity between three dental follicle tissue samples and three PDL tissue samples.** In each plot the *x*-axis (A) is 0.5 × \[log~2~(case)+log~2~ (control)\] and the *y*-axis (M) is log~2~ (case/control). The data of all plots were normally distributed.
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**Quantitative RT-PCR primers used in this study.**
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